Altogether, these data show that, likely in other obesity models, in childhood obesity, glucocorticoids also have permissive effects to induce hyperlipidemia and TG accumulation in the liver, probably by specific upregulation of one of the key enzymes of DNL: FASN. This evidence concerns the gene FASN and hyperlipidemia.